CTRP » Topics » p. Share-based compensation

This excerpt taken from the CTRP 20-F filed Jun 22, 2005.

p. Share-based compensation

 

The Company accounts for share-based compensation arrangements in accordance with Accounting Principles Board (“APB”) Opinion No. 25 - “Accounting for Stock Issued to Employees” (“APB No. 25”), and complies with the disclosure provisions of SFAS No. 123 - “Accounting for Stock-Based Compensation” (“SFAS No. 123”). In general, compensation cost under APB No. 25 is recognized based on the difference, if any, between the estimated fair value of the Company’s ordinary shares and the amount an employee is required to pay to acquire the ordinary shares, as determined on the date the option is granted. Total compensation cost as determined at the grant date of option is recorded in shareholders’ equity as additional paid-in capital with an offsetting entry recorded to deferred share-based compensation. Deferred share-based compensation is amortized on a straight-line basis and charged to expense over the vesting period of the underlying options.

 

If the compensation cost for the Company’s share-based compensation plan had been determined based on the estimated fair value at the grant dates for the share option awards as prescribed by SFAS No. 123, the Company’s net income (loss) attributable to ordinary shareholders and earnings (loss) per share would have resulted in the pro forma amounts disclosed below:

 

     2002

    2003

    2004

 
     RMB     RMB     RMB  

Net income (loss) attributable to ordinary shareholders as reported

   (19,061,315 )   1,373,167     133,126,290  

Add: Compensation expense under APB No. 25

   462,140     1,583,409     1,958,022  

Less: Compensation expense under SFAS No. 123

   (528,074 )   (2,172,399 )   (5,720,437 )
    

 

 

Pro forma net income (loss) attributable to ordinary shareholders

   (19,127,249 )   784,177     129,363,875  
    

 

 

Basic earnings (loss) per share

                  

— As reported

   (2.00 )   0.13     4.33  
    

 

 

— Pro forma

   (2.01 )   0.07     4.21  
    

 

 

Diluted earnings (loss) per share

                  

— As reported

   (2.00 )   0.11     4.23  
    

 

 

— Pro forma

   (2.01 )   0.06     4.11  
    

 

 

 

The effects of applying SFAS No. 123 methodology in this pro forma disclosure are not indicative of future amounts. Additional share option awards in future years are expected.

 

 

11


Table of Contents
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki